Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 7,435 | 6,272 | 6,283 | 6,735 | 4,388 |
| Operating Income | -7,435 | -6,272 | -6,283 | -6,735 | -4,388 |
| Other Income | 172 | 51 | 746 | 870 | -8,251 |
| Pre-tax Income | -7,263 | -6,220 | -5,537 | -5,865 | -12,638 |
| Net Income Continuous | -7,263 | -6,220 | -5,537 | -5,865 | -12,638 |
| Net Income | $-7,263 | $-6,220 | $-5,537 | $-5,865 | $-12,638 |
| EPS Basic Total Ops | -0.37 | -0.32 | -0.32 | -0.51 | -0.97 |
| EPS Basic Continuous Ops | -0.37 | -0.32 | -0.32 | -0.50 | -0.97 |
| EPS Diluted Total Ops | -0.37 | -0.32 | -0.32 | -0.18 | -0.97 |
| EPS Diluted Continuous Ops | -0.37 | -0.32 | -0.32 | -0.49 | -0.97 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.32 | -0.32 | -0.43 | -0.97 |
| EBITDA(a) | $-7,435 | $-6,272 | $-6,283 | $-6,735 | $-4,388 |